Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion

@article{Chadi2004ProtectiveAO,
  title={Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion},
  author={Gerson Chadi and Arbuthnott Er and Lars Ros{\'e}n and Ann Marie Janson and L. Agnati and Menek Goldstein and Sven Ove Ögren and Ralf F. Pettersson and Kjell Fuxe},
  journal={Experimental Brain Research},
  year={2004},
  volume={97},
  pages={145-158},
  url={https://api.semanticscholar.org/CorpusID:10649518}
}
Results indicate that hrFGF-2, directly and/or indirectly via astroglia, upon i.v.t. infusion exerts trophic effects on the nigrostriatal DA system and may increase survival of nigrostRIatal DA nerve cells exposed to the MPTP neurotoxin.

Involvement of astroglial fibroblast growth factor-2 and microglia in the nigral 6-OHDA parkinsonism and a possible role of glucocorticoid hormone on the glial mediated local trophism and wound repair.

The results indicate that reactive astroglia, but not reactive microglia, showed an increased FGF-2 IR in the process of DA cell degeneration induced by 6-OHDA, which may be related to the trophic state of DA neurons and the repair processes following DA lesion.

Impact of basic FGF expression in astrocytes on dopamine neuron synaptic function and development

It is demonstrated that under basal conditions (in the absence of a pharmacological stimulus such as amphetamine) bFGF is not secreted even though there is abundant nuclear expression in astrocytes, leading to enhanced DA release without a necessary change in synapse number.

Therapeutic effect of TO901317 on 6-OHDA-induced Parkinson rats in vitro and in vivo

After transplanting induced-cells into Parkinson's disease rats, the symptoms of Parkinson's rats decreased, and the number of dopamine neurons increased in the substantia nigra and striatum, suggesting that TO901317 may serve as a potential therapeutic methods for Parkinson's Disease.

Restorative Effects of Platelet Derived Growth Factor-BB in Rodent Models of Parkinson's Disease

In animal models of nigrostriatal injury, a two weeks treatment with platelet-derived growth factor-BB resulted in long-lasting restoration of striatal dopamine transporter binding sites and expression of nigral tyrosine hydroxylase and is considered a clinical candidate drug for treatment of Parkinson's disease.

GLIAL bFGF AND S100 IMMUNOREACTIVITIES INCREASE IN ASCENDING DOPAMINE PATHWAYS FOLLOWING STRIATAL 6-OHDA-INDUCED PARTIAL LESION OF THE NIGROSTRIATAL SYSTEM: A STEROLOGICAL ANALYSIS

The results open up the possibility that interactions between astroglial S100b and bFGF may be relevant to paracrine events related to repair and maintenance of remaining dopamine neurons following striatal 6-OHDA induced partial lesion of ascending midbrain dopamine pathway.

Aortic coarctation hypertension induces fibroblast growth factor-2 immunoreactivity in the stimulated nucleus tractus solitarii

The increased FGF-2 IR in the NTS cells following neuronal stimulation may represent trophic and plastic adaptive responses in this nucleus in an autocrine/paracrine fashion.

Fibroblast growth factor 9 prevents MPP+‐induced death of dopaminergic neurons and is involved in melatonin neuroprotection in vivo and in vitro

It is concluded that MPP+ down‐regulates FGF9 expression to cause DA neuron death and that the prevention of FGF 9 down‐regulation is involved in melatonin‐provided neuroprotection.
...

Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice

The results suggest that bFGF partially prevents the deleterious chemical and morphological consequences of an MPTP-mediated nigrostriatal lesion and mimics at least the morphological effects of chromaffin cell grafts to theMPTP-lesioned brain.

FGF‐2‐mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: Specificity and impact of culture conditions, non‐dopaminergic neurons, and astroglial cells

Data show that FGF‐2 can protect DAergic neurons against MPTP‐ and MPP+‐mediated damage, however, the effects of the toxins as well as of F GF‐2 are partially dependent on culture conditions.

Epidermal growth factor exerts neuronotrophic effects on dopaminergic and GABAergic CNS neurons: Comparison with basic fibroblast growth factor

EGF is also capable of enhancing the transmitter traits of selected central neuronal populations; however, the actions of bFGF appear to preferentially address dopaminergic cells.

The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia [published erratum appears in J Neurosci 1992 Mar;12(3):685]

Inhibition of glial proliferation abolished the neurotrophic effects exerted by aFGF or bFGF on dopaminergic neurons, and conditioned medium derived from mesencephalic glial cultures replated in the virtual absence of neurons also contained neurotrophic activity.

Evidence for a protective action of the vigilance promoting drug Modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis

SummaryBased on the observations that the psychostimulant drug amphetamine in combination with physiotherapy can promote recovery of brain function after brain injury, we have studied the ability of

Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey, and human.

RNA and immunoblot analysis confirmed the presence of both aFGF and bFGF mRNAs and proteins in the substantia nigra of rat, monkey, and human.
...